FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention describes a liquid pharmaceutical composition used in treatment of cancer and comprising vinorelbin as an active component and is useful for incapsulation into soft capsules. The liquid oral pharmaceutical composition useful as a liquid filling agent composition for the dosed formulation as a soft capsule comprises vinorelbin or its pharmaceutically acceptable salt, in particular, vinorelbin tartrate, ethanol, water, glycerol and polyethylene glycol. Also, invention relates to a method for preparing cancer that involves oral administration to a patient a soft capsule comprising the pharmaceutical composition. The liquid composition containing vinorelbin proves the improved solubility and bioavailability for oral administration.
EFFECT: improved and valuable pharmaceutical and medicinal properties of pharmaceutical composition.
13 cl, 7 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
STABLE PHARMACEUTICAL COMPOSITION OF WATER-SOLUBLE SALT OF VINORELBINE | 2008 |
|
RU2476208C2 |
ORAL ANTITUMOUR DRUGS AND METHOD FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2639479C1 |
STABLE SOLID DISPERSION OF VINCA ALKALOID DERIVATIVE AND METHOD FOR PRODUCING THEREOF | 2005 |
|
RU2412687C2 |
SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT | 1999 |
|
RU2257917C2 |
PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORIN DERIVATIVE AND A METHOD OF ITS PREPARING | 1993 |
|
RU2126263C1 |
PERORAL LIQUID COMPOSITIONS | 2000 |
|
RU2252019C2 |
ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE | 2009 |
|
RU2492860C2 |
ABT-263 CAPSULE | 2010 |
|
RU2550956C2 |
COMBINATION OF THERAPEUTICAL AGENTS (FOR EXAMPLE, CHLOROPROMAZINE AND PENTAMIDINE) FOR TREATING NEOPLASTIC DISORDERS | 2001 |
|
RU2286769C2 |
ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE | 2013 |
|
RU2670974C2 |
Authors
Dates
2006-07-20—Published
2003-05-28—Filed